Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
Background Pulmonary embolism (PE) is a potentially life‐threatening condition in which a
clot can migrate from the deep veins, most commonly in the leg, to the lungs. Conventional …
clot can migrate from the deep veins, most commonly in the leg, to the lungs. Conventional …
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
M Li, J Li, X Wang, X Hui, Q Wang, S Xie… - Cochrane Database …, 2023 - cochranelibrary.com
Inhibiteurs oraux directs de la thrombine ou inhibiteurs oraux du facteur Xa par rapport aux
anticoagulants classiques pour le traitement de l’embolie pulmonaire - Li, M - 2023 | Cochrane …
anticoagulants classiques pour le traitement de l’embolie pulmonaire - Li, M - 2023 | Cochrane …
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.
M Li, J Li, X Wang, X Hui, Q Wang, S Xie… - The Cochrane …, 2023 - europepmc.org
Background Pulmonary embolism (PE) is a potentially life-threatening condition in which a
clot can migrate from the deep veins, most commonly in the leg, to the lungs. Conventional …
clot can migrate from the deep veins, most commonly in the leg, to the lungs. Conventional …
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
M Li, J Li, X Wang, X Hui, Q Wang… - The Cochrane …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Pulmonary embolism (PE) is a potentially life-threatening condition in which a
clot can migrate from the deep veins, most commonly in the leg, to the lungs. Conventional …
clot can migrate from the deep veins, most commonly in the leg, to the lungs. Conventional …